JeffreyJSwigrisDO

PubMed

• Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Sympo...
  Ganesh Raghu, Marya Ghazipura, Thomas R Fleming, Kerri I Aronson, Jürgen Behr, Kevin K Brown, Kevin R Flaherty, Ella A Kazerooni, Toby M Maher, Luca Richeldi, Joseph A...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Mar 15
• First ever characterisation of the effects of short telomeres in a Singapore interstitial lung disease cohort.
  Michelle Li Wei Kam, Siao Ting Chong, Sock Hoai Chan, Jeffrey J Swigris, Ee Ling Chew, Yi Hern Tan, Joanne Yuen Yie Ngeow, Su Ying Low> ;Respiratory Investigation. 2024 Feb 28
• Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes.
  Humphries, S., Thieke, D., Baraghoshi, D., Strand, M., Chae, K., Hwang, H., Flaherty, K., Lee, C., Swigris, J., Oh, A., Adegunsoye, A., Jablonski, R., Husain, A., Chun...> ;American Journal of Respiratory and Critical Care Medicine. 2024 Jan 11
• 1 citations
  Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis.
  Wijsenbeek, M., Inoue, Y., Kreuter, M., Maher, T., Suda, T., Baldwin, M., Mueller, H., Rohr, K., , Swigris, J., Flaherty, K.> ;The European Respiratory Journal. 2024 Feb 1
• 1 citations
  Deep Learning-based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography...
  Andrea S Oh, David A Lynch, Jeffrey J Swigris, David Baraghoshi, Debra S Dyer, Valerie A Hale, Tilman L Koelsch, Cristina Marrocchio, Katherine N Parker, Stephen M Hum...> ;Annals of the American Thoracic Society. 2024 Feb 1
• Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung ...
  Jeffrey J Swigris, Sonye Danoff, Paul F Dellaripa, Tracy J Doyle, Joshua J Solomon> ;BMJ Open Respiratory Research. 2023 Sep 1
• Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?
  Kerri Aronson, Susan S Jacobs, Dawn Repola, Jeffrey J Swigris> ;BMJ Open Respiratory Research. 2023 Jul 1
• 1 citations
  Digital outcome measures in pulmonary clinical trials.
  Erica Farrand, Jeffrey J Swigris> ;Current Opinion in Pulmonary Medicine. 2023 Jul 1
• 3 citations
  Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort.
  Kerri I Aronson, Adam M Martin-Schwarze, Jeffrey J Swigris, Giselle Kolenic, Jamuna K Krishnan, Anna J Podolanczuk, Robert J Kaner, Monika M Safford, Laura C Pinheiro,...> ;American Journal of Respiratory and Critical Care Medicine. 2023 Jul 15
• 5 citations
  Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.
  Evans R Fernández Pérez, James L Crooks, David A Lynch, Stephen M Humphries, Tilman L Koelsch, Jeffrey J Swigris, Joshua J Solomon, Michael P Mohning, Steve D Groshong...> ;Thorax. 2023 Nov 1
• 2 citations
  Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved ...
  Timothy M Wilson, Joshua J Solomon, Stephen M Humphries, Jeffrey J Swigris, Faduma Ahmed, Hong Wang, Erika Darrah, M Kristen Demoruelle> ;The American Journal of the Medical Sciences. 2023 Jun 1
• 3 citations
  Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis.
  Nishant Gupta, Bin Zhang, Yuan Zhou, Francis X McCormack, Rebecca Ingledue, Nathan Robbins, Elizabeth J Kopras, Susan McMahan, Abhishek Singla, Jeffrey Swigris, Adam G...> ;Chest. 2023 May 1
• 16 citations
  Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
  Anna L Peljto, Rachel Z Blumhagen, Avram D Walts, Jonathan Cardwell, Julia Powers, Tamera J Corte, Joanne L Dickinson, Ian Glaspole, Yuben P Moodley, Martina Koziar Va...> ;American Journal of Respiratory and Critical Care Medicine. 2023 May 1
• Determining and reporting minimal important change for patient-reported outcome instruments in pulmonary medicine.
  Jeff Swigris, Brandon Foster, Nathan Johnson> ;The European Respiratory Journal. 2022 Oct 1
• 2 citations
  Reliability, Validity, and Responsiveness of the DEG, a Three-Item Dyspnea Measure.
  Duc M Ha, Lubin R Deng, Allison V Lange, Jeffrey J Swigris, David B Bekelman> ;Journal of General Internal Medicine. 2022 Aug 1
• 3 citations
  Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.
  Marlies Wijsenbeek, Maria Molina-Molina, Olivier Chassany, John Fox, Liam Galvin, Klaus Geissler, Katherine M Hammitt, Michael Kreuter, Teng Moua, Emily C O'Brien, Ash...> ;ERJ Open Research. 2022 Apr 1
• 6 citations
  Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibro...
  Jeffrey J Swigris, Donald M Bushnell, Klaus Rohr, Heiko Mueller, Michael Baldwin, Yoshikazu Inoue> ;BMJ Open Respiratory Research. 2022 Mar 1
• 20 citations
  Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic i...
  Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, Toby M Maher, Jonathan G Goldin, Scott M Palmer, Takafumi Suda, Takashi Ogura, Anne Minnich, Xiaojiang Zhan, Giridha...> ;BMJ Open Respiratory Research. 2021 Dec 1
• 15 citations
  A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen.
  Christopher S. King, Kevin R. Flaherty, Marilyn K. Glassberg, Lisa Lancaster, Ganesh Raghu, Jeffrey J. Swigris, Rahul G. Argula, Rosemarie A Dudenhofer, Neil A. Etting...> ;Annals of the American Thoracic Society. 2021 Oct 22
• 45 citations
  Decreased Fatty Oxidation and Altered Lactate Production During Exercise in Post-Acute COVID-19 Patients.
  Esther de Boer, Irina Petrache, Nir M Goldstein, J Tod Olin, Rebecca C. Keith, Brian D. Modena, Michael P. Mohning, Zulma X. Yunt, Iñigo San-Millán, Jeffrey J. Swigris> ;American Journal of Respiratory and Critical Care Medicine. 2021 Oct 19
• 17 citations
  Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.
  Kerri I. Aronson, Sonye K Danoff, Anne-Marie Russell, Christopher J. Ryerson, Atsushi Suzuki, Marlies S. Wijsenbeek, Sabrina Bajwah, Pauline Bianchi, Tamera J. Corte, ...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Jul 15
• 9 citations
  The Attitudes and Practices of Physicians Caring for Patients with Rheumatoid Arthritis-Interstitial Lung Disease: An International Survey.
  Joshua J. Solomon, Jeffrey J. Swigris, Michael Kreuter, Markus Polke, Kerri I. Aronson, Anna-Maria Hoffmann-Vold, Paul F. Dellaripa> ;Rheumatology. 2021 Jul 14
• 11 citations
  Managing Cough in Idiopathic Pulmonary Fibrosis.
  Yosafe Wakwaya, Deepa Ramdurai, Jeffrey J. Swigris> ;Chest. 2021 Jun 23
• 15 citations
  The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease.
  Jeffrey J. Swigris, Katelyn Cutts, Natalia Male, Michael Baldwin, Klaus B Rohr, Donald M. Bushnell> ;ERJ Open Research. 2021 Apr 1
• 3 citations
  Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
  Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshon...> ;ERJ Open Research. 2021 Apr 1
• Join now to see all